Combined meta-analysis of AD and PD GWAS revealed the lack of variants that increase the risk of developing both diseases [43]; although later on, a genetic overlap between AD and PD at the MAPT locus was detected [44] and recent studies have detected pathogenic PARK2 mutations in sporadic early onset AD cases [15]. Here, PRKN is linked to Alzheimer disease.